Overview Dividends

(NTR) Nutrien - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA67077M1086

Fertilizer, Crop Protection, Seed, Nutrient, Services

NTR EPS (Earnings per Share)

EPS Growth (3Y CAGR): -23.41%
EPS Trend (3Y Correlation): -25.6%

NTR Revenue

Revenue Growth (3Y CAGR): -8.27%
Revenue Trend (3Y Correlation): -15.0%

Risk via 10d forecast
Volatility	26.3%
Value at Risk 5%th	41.8%

Reward
Sharpe Ratio	0.81
Alpha	5.63

Character
Hurst Exponent	0.364
Beta	1.146

Drawdowns 3y
Max DD	44.33%
Mean DD	27.93%

Description: NTR Nutrien October 14, 2025

Nutrien Ltd. (NYSE: NTR) is the world’s largest provider of crop inputs and services, organized into four operating segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. The Ag Solutions arm sells nutrients, crop-protection chemicals, seeds and related merchandise, and also delivers agronomic services such as soil and leaf testing, precision-ag technology, water management, and financing to growers.

The Potash segment produces both granular and standard potash fertilizers, while the Nitrogen segment offers a portfolio that includes ammonia, urea, “environmentally smart” nitrogen products, nitrates and sulfates. The Phosphate segment supplies solid and liquid phosphate fertilizers as well as industrial and feed-grade phosphate products.

Key financial and operational metrics (2023) include roughly $27 billion in revenue, an EBITDA margin near 15 %, and net debt of about $6 billion. Production capacity is roughly 14 million tonnes of potash, 10 million tonnes of nitrogen, and 6 million tonnes of phosphate, positioning the firm to meet a sizable share of global fertilizer demand.

Primary economic drivers for Nutrien are global grain and oilseed production growth (which fuels fertilizer consumption), commodity price cycles for nitrogen, potash and phosphate, and regulatory trends that incentivize lower-emission nitrogen use. A sector-wide catalyst is the accelerating adoption of precision agriculture and digital agronomy services, which can boost the value of Nutrien’s Ag Solutions offerings.

For a deeper quantitative dive into Nutrien’s valuation metrics and scenario analysis, the ValueRay platform offers a free, data-rich snapshot worth exploring.

NTR Stock Overview

Market Cap in USD	27,492m
Sub-Industry	Fertilizers & Agricultural Chemicals
IPO / Inception	2018-01-02
Return 12m vs S&P 500	9.27%
Analyst Rating	3.88 of 5

NTR Dividends

Dividend Yield	3.69%
Yield on Cost 5y	6.24%
Yield CAGR 5y	4.66%
Payout Consistency	100.0%
Payout Ratio	53.8%

NTR Growth Ratios

CAGR	-5.34%
CAGR/Max DD Calmar Ratio	-0.12
CAGR/Mean DD Pain Ratio	-0.19
Current Volume	2364.9k
Average Volume	2115.1k

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (1.80b TTM) > 0 and > 6% of Revenue (6% = 1.59b TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA -0.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 15.80% (prev 10.98%; Δ 4.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 4.14b > Net Income 1.80b (YES >=105%, WARN >=100%)

Net Debt (13.54b) to EBITDA (5.58b) ratio: 2.43 <= 3.0 (WARN <= 3.5)

Current Ratio 1.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (485.8m) change vs 12m ago -1.84% (target <= -2.0% for YES)

Gross Margin 30.19% (prev 29.06%; Δ 1.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 51.23% (prev 51.16%; Δ 0.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 4.62 (EBITDA TTM 5.58b / Interest Expense TTM 691.6m) >= 6 (WARN >= 3)

Altman Z'' 2.68

(A) 0.08 = (Total Current Assets 14.46b - Total Current Liabilities 10.26b) / Total Assets 51.78b

(B) 0.23 = Retained Earnings (Balance) 11.83b / Total Assets 51.78b

(D) 0.94 = Book Value of Equity 25.04b / Total Liabilities 26.65b

Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 54.68

1. Piotroski 6.0pt = 1.0

2. FCF Yield 5.40% = 2.70

3. FCF Margin 8.35% = 2.09

4. Debt/Equity 0.56 = 2.34

5. Debt/Ebitda 2.43 = -0.82

6. ROIC - WACC (= -0.67)% = -0.84

7. RoE 7.32% = 0.61

8. Rev. Trend -15.01% = -1.13

9. EPS Trend -25.59% = -1.28

What is the price of NTR shares?

As of November 11, 2025, the stock is trading at USD 58.94 with a total of 2,364,896 shares traded.
Over the past week, the price has changed by +8.09%, over one month by -1.50%, over three months by +5.65% and over the past year by +25.88%.

Is Nutrien a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Nutrien is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 54.68 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NTR is around 57.47 USD . This means that NTR is currently overvalued and has a potential downside of -2.49%.

Is NTR a buy, sell or hold?

Nutrien has received a consensus analysts rating of 3.88. Therefore, it is recommended to buy NTR.

Strong Buy: 10
Buy: 5
Hold: 8
Sell: 1
Strong Sell: 1

What are the forecasts/targets for the NTR price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	67.2	14%
Analysts Target Price	67.2	14%
ValueRay Target Price	63.3	7.3%

NTR Fundamental Data Overview November 10, 2025

Market Cap USD = 27.49b (27.49b USD * 1.0 USD.USD)
P/E Trailing = 15.3315
P/E Forward = 11.8483
P/S = 1.071
P/B = 1.1571
P/EG = 0.6101
Beta = 1.146
Revenue TTM = 26.56b USD
EBIT TTM = 3.20b USD
EBITDA TTM = 5.58b USD
Long Term Debt = 8.88b USD (from longTermDebt, last fiscal year)
Short Term Debt = 3.37b USD (from shortTermDebt, last quarter)
Debt = 14.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.54b USD (from netDebt column, last quarter)
Enterprise Value = 41.04b USD (27.49b + Debt 14.17b - CCE 623.4m)
Interest Coverage Ratio = 4.62 (Ebit TTM 3.20b / Interest Expense TTM 691.6m)
FCF Yield = 5.40% (FCF TTM 2.22b / Enterprise Value 41.04b)
FCF Margin = 8.35% (FCF TTM 2.22b / Revenue TTM 26.56b)
Net Margin = 6.79% (Net Income TTM 1.80b / Revenue TTM 26.56b)
Gross Margin = 30.19% ((Revenue TTM 26.56b - Cost of Revenue TTM 18.54b) / Revenue TTM)
Gross Margin QoQ = 32.70% (prev 30.42%)
Tobins Q-Ratio = 0.79 (Enterprise Value 41.04b / Total Assets 51.78b)
Interest Expense / Debt = 1.19% (Interest Expense 168.1m / Debt 14.17b)
Taxrate = 26.37% (166.1m / 629.9m)
NOPAT = 2.35b (EBIT 3.20b * (1 - 26.37%))
Current Ratio = 1.41 (Total Current Assets 14.46b / Total Current Liabilities 10.26b)
Debt / Equity = 0.56 (Debt 14.17b / totalStockholderEquity, last quarter 25.09b)
Debt / EBITDA = 2.43 (Net Debt 13.54b / EBITDA 5.58b)
Debt / FCF = 6.11 (Net Debt 13.54b / FCF TTM 2.22b)
Total Stockholder Equity = 24.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.48% (Net Income 1.80b / Total Assets 51.78b)
RoE = 7.32% (Net Income TTM 1.80b / Total Stockholder Equity 24.66b)
RoCE = 9.54% (EBIT 3.20b / Capital Employed (Equity 24.66b + L.T.Debt 8.88b))
RoIC = 6.39% (NOPAT 2.35b / Invested Capital 36.87b)
WACC = 7.05% (E(27.49b)/V(41.66b) * Re(10.24%) + D(14.17b)/V(41.66b) * Rd(1.19%) * (1-Tc(0.26)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.92%
[DCF Debug] Terminal Value 62.69% ; FCFE base≈2.26b ; Y1≈1.57b ; Y5≈801.3m
Fair Price DCF = 23.11 (DCF Value 11.17b / Shares Outstanding 483.3m; 5y FCF grow -35.86% → 3.0% )
EPS Correlation: -25.59 | EPS CAGR: -23.41% | SUE: 0.30 | # QB: 0
Revenue Correlation: -15.01 | Revenue CAGR: -8.27% | SUE: 0.84 | # QB: 0

Additional Sources for NTR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle